Pelage Pharmaceuticals Announces $16.75M Series A
02/27/24, 2:43 PM
Location
los angelesMoney raised
$16.8 million
Industry
biotechnology
healthcare
Round Type
series a
Investors
Yk Bio Ventures, Visionary Ventures, Main Street Advisors, Gv
Pelage Pharmaceuticals raised $16.75M in Series A funding led by GV with participation from Main Street Advisors, Visionary Ventures, and YK BioVentures. The company plans to use the funds to advance a first-in-class treatment for androgenetic alopecia, pattern baldness, and other types of alopecia, including chemotherapy-induced hair loss.
Company Info
Location
los angeles, california, united states
Additional Info
At Pelage Pharmaceuticals, our goal is to deliver a scientifically based, clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss.
Based on the breakthrough innovation by Pelage Pharmaceuticals co-founders, we stimulate hair growth by targeting the metabolism of hair follicle stem cells in most forms of alopecia.